Bright Minds Biosciences, Inc. (DRUG.CX)
106.33
-4.39
(-3.96%)
CAD |
CNSX |
Dec 30, 10:09
Bright Minds Biosciences Total Assets (Quarterly): 84.42M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| 4Front Ventures Corp. | 375.68M |
| Green Thumb Industries, Inc. | 3.672B |
| Lowell Farms, Inc. | 38.42M |
| Vireo Growth, Inc. | 944.65M |
| Wesana Health Holdings, Inc. | 0.6679M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.377M |
| Shareholders Equity (Quarterly) | 82.04M |
| Debt to Equity Ratio | 0.0015 |
| Current Ratio | 36.10 |
| Net Debt Paydown Yield | -0.00% |